Who has invested in Secretome Therapeutics?

RA Capital Management are named among the investors backing Secretome Therapeutics.

Secretome Therapeutics Funding: $30M Raised, Series A (2026)

Secretome Therapeutics funding overview

Secretome Therapeutics is based in Plano. Secretome Therapeutics has raised $30M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2026. The round record for Secretome Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include RA Capital Management.

Secretome Therapeutics at a glance

Total raised: $30M
Latest round: Series A
Latest round date: May 2026
Headquarters: Plano
Notable investors: RA Capital Management

Frequently asked about Secretome Therapeutics funding

How much has Secretome Therapeutics raised?: Secretome Therapeutics has raised $30M in total disclosed funding across the rounds on record.
Who has invested in Secretome Therapeutics?: RA Capital Management are named among the investors backing Secretome Therapeutics.
What was the latest Secretome Therapeutics funding round?: The most recent disclosed round is a Series A, announced in May 2026.
Where is Secretome Therapeutics based?: Secretome Therapeutics is based in Plano.
When did Secretome Therapeutics last raise?: The last disclosed Secretome Therapeutics round closed in May 2026 at Series A.

Secretome Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Plano below to benchmark round size and investor mix.

Secretome Therapeutics Funding: $30M Raised, Series A (2026)

Secretome Therapeutics funding overview

Secretome Therapeutics at a glance

Frequently asked about Secretome Therapeutics funding

Companies related to Secretome Therapeutics (33)

Browse related funding lists (4)